Accordingly, the enhanced TRAIL susceptibility of the spheroid-cultured gastric cancer cells seems to be associated with a tendency of CD44 upregulation and an increased expression of DR4 and DR5 upon the spheroid culture of the gastric cancer cells. The gene discussed is CD44; the disease is gastric cancer.